1. Home
  2. GASS vs BNTC Comparison

GASS vs BNTC Comparison

Compare GASS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GASS

StealthGas Inc.

N/A

Current Price

$7.39

Market Cap

297.3M

ML Signal

N/A

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$7.92

Market Cap

315.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GASS
BNTC
Founded
2004
1995
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.3M
315.4M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
GASS
BNTC
Price
$7.39
$7.92
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $23.75
AVG Volume (30 Days)
140.9K
★ 154.2K
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.00
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.66
$7.89
52 Week High
$10.55
$14.39

Technical Indicators

Market Signals
Indicator
GASS
BNTC
Relative Strength Index (RSI) 29.37 37.62
Support Level N/A N/A
Resistance Level $9.00 $13.87
Average True Range (ATR) 0.27 0.66
MACD -0.04 -0.08
Stochastic Oscillator 2.63 5.18

Price Performance

Historical Comparison
GASS
BNTC

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: